FDA Panel on Peptides Will Include Experts Who Promote the Unproven Chemicals

(MedPage Today) — When U.S. health officials meet next month to reconsider a list of controversial peptide drugs, they will hear from a new set of voices: doctors and pharmacists with deep financial ties to the burgeoning industry of unproven…